Tenascin in normal, reactive, hyperplastic, and neoplastic tissues: biologic and pathologic implications.
about
Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-CPrognostic significance of tenascin-C expression in superficial and invasive bladder cancerA novel, nuclear pore-associated, widely distributed molecule overexpressed in oncogenesis and developmentFormation of cysts by alveolar type II cells in three-dimensional culture reveals a novel mechanism for epithelial morphogenesis.Influence of interleukin 1 beta on tenascin distribution in human normal and osteoarthritic cartilage: a quantitative immunohistochemical study.Interpretation of ileal biopsies: morphological features in normal and diseased mucosa.Tenascin-C enhances pancreatic cancer cell growth and motility and affects cell adhesion through activation of the integrin pathwayNucleic acid aptamers: clinical applications and promising new horizonsBreast cancer with neoductgenesis: histopathological criteria and its correlation with mammographic and tumour features.Expression of tenascin-C in aseptic loosening of total hip replacement.Tenascin C expression is upregulated in pancreatic cancer and correlates with differentiationcDNA microarray analysis of cancer associated gene expression profiles in malignant peripheral nerve sheath tumours.Immunohistochemical localization of integrins in the normal, hyperplastic, and neoplastic breast. Correlations with their functions as receptors and cell adhesion molecules.Enhanced tenascin expression in cervical and vulvar koilocytotic lesions.Constitutive expression of tenascin in T-dependent zones of human lymphoid tissues.Expression of the extracellular matrix protein tenascin in malignant and benign ovarian tumours.Prognostic and predictive markers in canine tumours: rationale and relevance. A review.Expression and degeneration of tenascin-C in human lung cancersDownregulation of tenascin expression by glucocorticoids in bone marrow stromal cells and in fibroblasts.Modulation of response to tumor therapies by the extracellular matrix.Distribution of tenascin in healing incision, excision and laser wounds.Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II.Nucleic acid aptamers for targeting of shRNA-based cancer therapeutics.Tenascin-C aptamers are generated using tumor cells and purified protein.Molecular recognition force spectroscopy study of the dynamic interaction between aptamer GBI-10 and extracellular matrix protein tenascin-C on human glioblastoma cell.Beta1 integrin promotes but is not essential for metastasis of ras-myc transformed fibroblasts.Inhibition of tenascin-C expression in mammary epithelial cells by thyroid hormone.Tenascin and fibronectin expression in human mesothelial cells and pleural mesothelioma cell-line cells.Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases.Production and characterization of monoclonal antibodies specific for different epitopes of human tenascin.A simple procedure for tenascin purification.Regulation of extracellular matrix proteins and integrin cell substratum adhesion receptors on epithelium during cutaneous human wound healing in vivo.Multicellular origin of tenascin in skin tumors--an in situ hybridization study.Tenascin-C patterns and splice variants in actinic keratosis and cutaneous squamous cell carcinoma.Degradation of extracellular matrix protein tenascin-C by cathepsin B: an interaction involved in the progression of gliomas.Over-expression of tenascin-C in malignant pleural mesothelioma.The expression of gicerin, a cell adhesion molecule, in regenerating process of collecting ducts and ureters of the chicken kidney following infection with a nephrotropic strain of infectious bronchitis virus.Tenascin-C Is Associated with Cored Amyloid-β Plaques in Alzheimer Disease and Pathology Burdened Cognitively Normal Elderly.Chemical modification improves the stability of the DNA aptamer GBI-10 and its affinity towards tenascin-C.Tenascin labelling in colorectal biopsies: a useful marker in the diagnosis of collagenous colitis.
P2860
Q24651368-B55EAFD5-C957-4D41-B820-1F3033D544F2Q24672629-70ABFA74-13A0-4D47-A36B-8B0EEF395F87Q24677653-ED833384-1B3C-4E89-8EF8-84FA1CB3D40FQ30479326-9DE49C89-8580-4671-A412-791AA250D428Q33579367-D472AD26-EDB0-4354-A84A-3255B4B6FA36Q33929657-3BF8AB11-D7A2-4B13-AEC1-7203BD19E457Q33957943-06763977-B46A-45C9-8878-233672A86245Q34028112-CA289772-7DBD-428A-BBCC-742071863ED7Q34454213-11A9DECF-F011-4E88-8565-ECD2CA42A9A5Q35547558-83AF6A58-970C-47CB-AEFD-8DC8263E5A33Q35588136-DB526BDE-5764-479F-A5DA-4F3D5A5B9226Q35769723-DEC77060-54C3-4D47-9740-4EECA0CEB7FBQ35831087-23CF9868-E26F-4117-8A24-8DA85B479035Q35831973-7ED15182-6528-49BA-80DE-EBB1CC498585Q35833492-F35E8B0B-623A-465C-9D3F-7C4312996BCAQ36140966-1153F02D-7AC0-4BBB-B47D-F3B224BC6400Q36196363-C62C44A0-0C38-41E6-93ED-E211647C1106Q36294957-EBDEDE9B-4514-453D-A371-DA0166BDC4D3Q36383276-8C44DBA6-88BE-47ED-A0C4-755E0C5D2BF4Q36512542-B2430A59-20A0-4FFD-A8E9-34BBAA0E17BCQ36694913-C0B745A0-1094-4E74-AD04-250A1023E8D3Q37381233-629B5365-8437-4C00-9975-05B21A44C33DQ37586838-396C059A-7017-42B5-8B3B-C5AD9E66C378Q38296050-87C37AE1-067C-4D49-BD8D-879F55137DFDQ38318879-BFD747C4-13C7-4F99-8F56-85E4A5D8E36BQ40935824-C9F728CF-C527-445A-9196-BFEC4036AF10Q40966899-0F0B1879-7AA6-4F91-8DC8-FF44A0E016F6Q41010485-2657B40E-2CEC-4983-BE23-C50E44E6E19EQ41350591-E88C7CD5-0C69-41D7-91AD-9D8C90C31FCEQ41521191-CE15A009-0B66-457A-BABF-35E0FA7AF10FQ41629024-25122A51-FF4F-4B01-A5D4-B80D396EB96BQ41835080-CF2A1017-BE53-4C52-8C6C-F93899702EAFQ42450142-E781DE15-856E-4720-9A86-28DD4B6072C2Q42501211-F8E87FAA-0A77-4073-AE8F-C40C2516B305Q44219945-A1435A57-EE48-46B3-8B1D-998840541EC0Q44328118-4789FF10-03A1-48B9-B311-02DCA6FCC025Q45395020-3B28BA97-5F50-41BF-86E0-4A46602EBE17Q46633367-ECABDDAD-5A6B-421B-A2EA-E7D438BAFA96Q48354970-B61E84E5-E1D3-4EF9-B825-8C0AE4DD53A3Q52979185-5D898DF2-777E-4374-8E71-47C362DBD51D
P2860
Tenascin in normal, reactive, hyperplastic, and neoplastic tissues: biologic and pathologic implications.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Tenascin in normal, reactive, ...... c and pathologic implications.
@ast
Tenascin in normal, reactive, ...... c and pathologic implications.
@en
type
label
Tenascin in normal, reactive, ...... c and pathologic implications.
@ast
Tenascin in normal, reactive, ...... c and pathologic implications.
@en
prefLabel
Tenascin in normal, reactive, ...... c and pathologic implications.
@ast
Tenascin in normal, reactive, ...... c and pathologic implications.
@en
P2093
P1433
P1476
Tenascin in normal, reactive, ...... c and pathologic implications.
@en
P2093
Bhattacharyya A
Howeedy AA
Koukoulis GK
Virtanen I
P304
P356
10.1016/0046-8177(91)90285-W
P407
P577
1991-07-01T00:00:00Z